Increasing Support for Smoke-free Alternatives among Serbian Consumers

Aug.29.2024
Increasing Support for Smoke-free Alternatives among Serbian Consumers
Serbian consumers increasingly believe smoking bans are necessary, but many think smokeless devices should be exempt.

According to a report from 021.RS on August 28, the Serbian National Consumer Organization (NOPS) has noted a significant increase in the number of people who believe that a smoking ban is necessary. However, many individuals argue that smoke-free smoking devices should be exempt from the ban.


According to a press release from NOPS, the results of the third survey on alternative tobacco and nicotine products show that last year, 23% of respondents believed that the use of smokeless smoking devices should be allowed. This year, that percentage has risen to 63%, with individuals believing that these devices should be allowed for use even in restaurants and cafes where smoking is prohibited.


Marko Dragić, a member of the organization, stated that these "rather contradictory results" indicate that consumers, whether smokers or non-smokers, lack sufficient relevant information about these products.


A study conducted by NOPS surveyed 2,000 participants and found that 18% of respondents used heated tobacco products, while approximately 5% used e-cigarettes.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia Leads COP11 Seminars as Exploding Illicit Tobacco Market Raises Questions
Australia Leads COP11 Seminars as Exploding Illicit Tobacco Market Raises Questions
Australia sent a delegation to COP11 in Switzerland and is leading three major seminars to showcase its vape and tobacco control policies. But at home, illicit cigarette sales are skyrocketing amid record-high taxes, drawing criticism from the tobacco industry and prompting doubts over policy effectiveness.
Nov.20 by 2FIRSTS.ai
British American Tobacco’s Irish unit says VELO pouch sales hit 29m, net revenue climbs to €33.75m
British American Tobacco’s Irish unit says VELO pouch sales hit 29m, net revenue climbs to €33.75m
British American Tobacco’s Irish subsidiary PJ Carroll & Co Ltd reported that sales of its Velo nicotine pouches nearly quintupled in 2024 to 29 million units, driving an 11% year-on-year increase in net revenue to €33.75 million. However, amid a heavy tax burden and declining traditional cigarette volumes, the company’s pre-tax profit fell 8% to €5.69 million.
Dec.01 by 2FIRSTS.ai
KT&G Unveils lil hybrid 3.0 Misty Rose Limited Edition, Limited to 20,000 Devices
KT&G Unveils lil hybrid 3.0 Misty Rose Limited Edition, Limited to 20,000 Devices
KT&G has launched the limited-edition “lil hybrid 3.0 Misty Rose Edition” heated tobacco device in South Korea, betting on year-end consumer demand with a gradient rose-colored design. The release is capped at 20,000 units and is available through both online and offline channels, with an official retail price of 78,000 won (approximately USD 53).
Nov.20 by 2FIRSTS.ai
Ukraine Military Voices Concern Over Potential Vape and Pouch Ban
Ukraine Military Voices Concern Over Potential Vape and Pouch Ban
Verkhovna Rada is reviewing six bills to regulate new nicotine products such as pouches and vapes. The main bill, No.14110, proposes a total ban on production, import, and sale, while alternative proposals seek regulation instead of prohibition.
Nov.10 by 2FIRSTS.ai
U.S. Virginia’s “Operation Magic Dragon” Targets 172 Vape Shops
U.S. Virginia’s “Operation Magic Dragon” Targets 172 Vape Shops
Virginia State Police (VSP) launched “Operation Magic Dragon,” identifying 172 businesses allegedly selling marijuana and related products via vape shops. The multi-month probe uncovered cocaine, methamphetamine, psilocybin and illegal firearms. Western VA seizures included 128.9 kg marijuana and 4.3 kg THC vapes; two Roanoke County raids hit a retail site and a freight distributor. Governor Glenn Youngkin vowed decisive enforcement.
Oct.31 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai